Prognostic factors of patients with metastatic renal cell carcinoma with removed metastases: A multicenter study of 556 patients

Urology

Volumn 82, Issue 4, 2013, Pages 846-851

  Naito, Sei ^b   Kinoshita, Hidefumi ^b   Kondo, Tsunenori ^b   Shinohara, Nobuo ^b   Kasahara, Takashi ^b   Saito, Kazutaka ^b   Takayama, Tatsuya ^b   Masumori, Naoya ^b   Takahashi, Wataru ^b   Takahashi, Masayuki ^b   Terachi, Toshiro ^b   Ozono, Seiichiro ^b   Naito, Seiji ^b   Tomita, Yoshihiko ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CALCIUM; HEMOGLOBIN; LACTATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CALCIUM BLOOD LEVEL; CANCER CELL; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CELL NUCLEUS; CLEAR CELL CARCINOMA; CORRELATIONAL STUDY; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY CARCINOMA; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS RESECTION; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; METASTASECTOMY; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84884967210     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2013.06.035     Document Type: Article

References (21)

1. J. Ferlay, H.R. Shin, and F. Bray Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
2. R.M. Bukowski Natural history and therapy of metastatic renal cell carcinoma: the role of interleukin-2 Cancer 80 1997 1198 1220
3. G.G. Ritchie Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial. Medical Research Council Renal Cancer Collaborators Lancet 353 1999 14 17
4. S. Naito, N. Yamamoto, and T. Takayama Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients Eur Urol 57 2009 317 325
5. B.C. Leibovich, J.C. Cheville, and C.M. Lohse A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials J Urol 174 2005 1759 1763 discussion 1763
6. U.M. Vogl, H. Zehetgruber, and M. Dominkus Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable Br J Cancer 95 2006 691 698
7. R.J. Motzer, J. Bacik, and B.A. Murphy Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma J Clin Oncol 20 2002 289 296
8. R.J. Motzer, T.E. Hutson, and P. Tomczak Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma J Clin Oncol 27 2009 3584 3590
9. G. Hudes, M. Carducci, and P. Tomczak Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma N Engl J Med 356 2007 2271 2281
10. M.E. Gore, C.L. Griffin, and B. Hancock Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial Lancet 375 2010 641 648
11. G. Fyfe, R.I. Fisher, and S.A. Rosenberg Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy J Clin Oncol 13 1995 688 696
12. S.E. Eggener, O. Yossepowitch, and S. Kundu Risk score and metastasectomy independently impact prognosis of patients with recurrent renal cell carcinoma J Urol 180 2008 873 878 discussion 878
13. J.P. Kavolius, D.P. Mastorakos, and C. Pavlovich Resection of metastatic renal cell carcinoma J Clin Oncol 16 1998 2261 2266
14. Association JU. General Rule for Clinical and Pathological Studies on Renal Cell Carcinoma. The Japanese Urological Association and The Japanese Society of Pathology and Japan Radiological Society 2011;4th.
15. S.A. Fuhrman, L.C. Lasky, and C. Limas Prognostic significance of morphologic parameters in renal cell carcinoma Am J Surg Pathol 6 1982 655 663
16. D.H. Orrell Albumin as an aid to the interpretation of serum calcium Clin Chim Acta 35 1971 483 489
17. J.D. Barney, and B.M. Churchill Adenocarcinoma of the kidney with metastasis to the lung: cured by nephrectomy and lobectomy J Urol 42 1939 269 276
18. D.Y. Heng, W. Xie, and M.M. Regan Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study J Clin Oncol 27 2009 5794 5799
19. D.D. Daliani, N.M. Tannir, and C.N. Papandreou Prospective assessment of systemic therapy followed by surgical removal of metastases in selected patients with renal cell carcinoma BJU Int 104 2009 456 460
20. A.L. Alt, S.A. Boorjian, and C.M. Lohse Survival after complete surgical resection of multiple metastases from renal cell carcinoma Cancer 117 2011 2873 2882
21. H.G. van der Poel, J.A. Roukema, and S. Horenblas Metastasectomy in renal cell carcinoma: a multicenter retrospective analysis Eur Urol 35 1999 197 203